-
GTA 6 Release Date Confirmed for November 19; Troubleshooting Pre-load and Launch Errors
-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
Olenox October Bitcoin Production Climbs to Three-Month High as Uptime and Hashrate Advance
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Dermata Announces U.S. Trademark Registration for TOME(R)
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
Healthcare AI Shakeout: Health Systems Plan to Cut AI Vendors Nearly in Half by 2028, Black Book Finds
-
Sparta Capital Ltd. Announces Resumption of Trading
-
TrizCom PR Wins Fourth PRSA Dallas Best of Show Award; Founder Jo Trizila Receives Norm Teich Award
-
CORRECTION FROM SOURCE: Nixxy Announces 1-for-20 Reverse Stock Split
-
Olenox Secures Texas Pipeline Operating Permit, Clearing Path for Initial 4 MW Power Deployment
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
Encision Reports First Quarter Fiscal Year 2026 Results
BOULDER, CO / ACCESS Newswire / August 15, 2025 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 first quarter that ended June 30, 2025.
The Company posted quarterly product net revenue of $1.49 million and service net revenue of $110 thousand, or total net revenue of $1.6 million for a quarterly net loss of $41 thousand, or $0.00 per diluted share. These results compare to product net revenue of $1.59 million and service net revenue of $38 thousand, or total net revenue of $1.63 million for a quarterly net income of $22 thousand, or $(0.00) per diluted share, in the year-ago quarter. Gross margin on product net revenue was 55% in the fiscal 2026 first quarter and 58% in the fiscal 2025 first quarter.
Encision Inc. designs and markets a portfolio of high-performance surgical instrumentation that delivers advances in patient safety with AEM technology, surgical performance, and value to hospitals across a broad range of minimally invasive surgical procedures. Based in Boulder, Colorado, the company pioneered the development and deployment of Active Electrode Monitoring, AEM technology, to eliminate dangerous stray energy burns during minimally invasive procedures. For additional information about all our products, please visit www.encision.com.
In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to develop new or enhanced products and have such products accepted in the market, its ability to increase net sales through the Company's distribution channels, its ability to compete successfully against other manufacturers of surgical instruments, insufficient quantity of new account conversions, insufficient cash to fund operations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission. Readers are encouraged to review the risk factors and other disclosures appearing in the Company's Annual Report on Form 10-K for the year ended March 31, 2024 and subsequent filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements, whether as a result of the receipt of new information, future events, or otherwise.
CONTACT: Brandon Shepard , Encision Inc., 303-444-2600, [email protected]
Encision Inc.
Condensed Balance Sheets
June 30, 2025 | March 31, 2025 | |||
Unaudited | Audited | |||
ASSETS | ||||
Current assets: | ||||
Cash | $ | 47,918 | $ | 257,433 |
Accounts receivable | 749,426 | 786,471 | ||
Inventories | 1,534,887 | 1,483,182 | ||
Prepaid expenses | 118,308 | 85,679 | ||
Total current assets | 2,450,539 | 2,612,765 | ||
Equipment: | ||||
Furniture, fixtures, and equipment, at cost | 2,591,981 | 2,585,446 | ||
Accumulated depreciation | (2,358,134 | ) | (2,340,689 | ) |
Equipment, net | 233,847 | 244,757 | ||
Right of use asset, net | 1,199,806 | 568,395 | ||
Patents, net | 166,708 | 171,890 | ||
Other assets | 80,655 | 72,892 | ||
TOTAL ASSETS | 4,131,555 | 3,670,699 | ||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||
Current liabilities: | ||||
Accounts payable | $ | 328,123 | $ | 346,900 |
Line of credit | 320,440 | 395,964 | ||
Secured notes | 39,802 | 44,128 | ||
Accrued compensation | 208,850 | 180,850 | ||
Deferred Revenue | 2,574 | 17,401 | ||
Other accrued liabilities | 129,615 | 160,274 | ||
Accrued lease liability | 248,469 | 430,398 | ||
Total current liabilities | 1,277,873 | 1,575,915 | ||
Long-term liability: | ||||
Secured notes | 169,997 | 177,470 | ||
Accrued lease liability | 1,061,597 | 266,212 | ||
Total liabilities | 2,509,467 | 2,019,597 | ||
Commitments and contingencies (Note 4) | ||||
Shareholders' equity: | ||||
Preferred stock, no par value: 10,000,000 shares authorized; none issued and outstanding | - | - | ||
Common stock and additional paid-in capital, no par value: 100,000,000 shares authorized; 11,879,645 and 11,879,645 issued and outstanding at June 30, 2025, and March 31, 2025, respectively | 24,428,466 | 24,416,347 | ||
Accumulated (deficit) | (22,806,378 | ) | (22,765,245 | ) |
Total shareholders' equity | 1,622,088 | 1,651,102 | ||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ | 4,131,555 | $ | 3,670,699 |
Encision Inc.
Condensed Statements of Operations
(Unaudited)
Three Months Ended | ||||||
June 30, 2025 | June 30, 2024 | |||||
NET REVENUE: | ||||||
Product | $ | 1,492,832 | $ | 1,591,960 | ||
Service | 109,896 | 38,971 | ||||
Total revenue | 1,602,728 | 1,630,931 | ||||
COST OF REVENUE: | ||||||
Product | 666,811 | 667,635 | ||||
Service | 57,458 | 20,633 | ||||
Total cost of revenue | 724,269 | 688,268 | ||||
GROSS PROFIT | 878,459 | 942,663 | ||||
OPERATING EXPENSES: | ||||||
Sales and marketing | 404,601 | 423,237 | ||||
General and administrative | 328,198 | 351,903 | ||||
Research and development | 165,440 | 139,180 | ||||
Total operating expenses | 898,239 | 914,320 | ||||
OPERATING (LOSS) INCOME | (19,780 | ) | 28,343 | |||
Interest expense, net | (18,009 | ) | (6,369 | ) | ||
Other (expense) income, net | (3,344 | ) | 67 | |||
Interest expense and other (expense), income, net | (21,353 | ) | (6,302 | ) | ||
(LOSS) INCOME BEFORE PROVISION FOR INCOME TAXES | (41,133 | ) | 22,041 | |||
Provision for income taxes | - | - | ||||
NET (LOSS) INCOME | $ | (41,133 | ) | $ | 22,041 | |
Net (loss) income per share-basic and diluted | $ | (0.00 | ) | $ | (0.00 | ) |
Weighted average shares-basic | 11,879,645 | 11,879,145 | ||||
Weighted average shares-diluted | 11,879,645 | 11,906,918 | ||||
Encision Inc.
Condensed Statements of Cash Flows
(Unaudited)
Three Months Ended | June 30, 2025 | June 30, 2024 | |||
Cash flows (used in) operating activities: | |||||
Net (loss) income | $ | (41,133 | ) | $ | 22,041 |
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | |||||
Depreciation and amortization | 22,777 | 19,322 | |||
Stock-based compensation expense | 12,119 | 12,374 | |||
Provision for inventory obsolescence, net change | 3,982 | 1,090 | |||
Change in operating assets and liabilities: | |||||
Right of use asset, net | (17,955 | ) | (3,456 | ) | |
Accounts receivable | 37,046 | 74,980 | |||
Inventories | (55,687 | ) | 83,125 | ||
Prepaid expenses and other assets | (40,393 | ) | (21,587 | ) | |
Accounts payable | (33,605 | ) | (76,123 | ) | |
Accrued compensation and other accrued liabilities | (2,659 | ) | 5,762 | ||
Net cash provided by (used in) provided by operating activities | (115,508 | ) | 117,528 | ||
Cash flows (used in) investing activities: | |||||
Acquisition of property and equipment | (6,535 | ) | (14,144 | ) | |
Patent costs | (150 | ) | (5,397 | ) | |
Net cash (used in) investing activities | (6,685 | ) | (19,541 | ) | |
Cash flows from financing activities: | |||||
(Payments) to borrowing from line of credit | (75,524 | ) | 142,736 | ||
(Payments) from options exercised | - | (1,449 | ) | ||
(Paydown) Secured notes | (11,798 | ) | (11,339 | ) | |
Net cash (used in) provided by financing activities | (87,322 | ) | 129,948 | ||
Net (decrease) increase in cash | (209,515 | ) | 227,935 | ||
Cash, beginning of fiscal year | 257,433 | 42,509 | |||
Cash, end of fiscal quarter | 47,918 | 270,444 | |||
Supplemental disclosures of cash flow information: | |||||
Cash paid during the period for interest | $ | 18,009 | $ | 6,369 | |
SOURCE: Encision, Inc.
View the original press release on ACCESS Newswire
H.Romero--AT